CanadaBis Capital Inc.

CANB

CA13530Q1046

Drug Retailers

Market Closed - Toronto S.E. Other stock markets 07:00:00 15/07/2024 pm IST			5-day change	1st Jan Change
0.06 ^CAD	0.00%		-7.69%	-76.47%

26/06	CanadaBis Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
07/05	Canadabis Capital Signs Pact to Expand Into Europe	MT

CanadaBis Capital Inc. Signs Contracts with British Columbia, Alberta, Saskatchewan and Manitoba

January 21, 2021 at 06:46 pm IST

CanadaBis Capital Inc. announced that is has signed Contracts with British Columbia, Alberta, Saskatchewan and Manitoba, and are currently working with Ontario to finalize an agreement with their wholesale department to supply products for both their medical and recreational clients.

Latest news about CanadaBis Capital Inc.

CanadaBis Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	26/06	CI
Canadabis Capital Signs Pact to Expand Into Europe	07/05	MT
CanadaBis Capital Brief: Expanding into European Market with EU-GMP Partners	07/05	MT
Canadabis Capital Inc. with Stigma Grow Announce Its Strategic Expansion into the European Market Through A Significant Distribution Agreement	07/05	CI
CanadaBis Capital Unveils New 60%+ Double-Infused Pre-Roll Under Dab Bods Brand; Says "Setting New Standard" For THC Potency In Canada Market	23/04	MT
Canadabis Capital Inc. Unveils New 60%+ Double- Infused Pre-Roll Under Dab Bods Brand	23/04	CI
CanadaBis Capital, With Sub Stigma Grow, Fiscal Q2 2024 Net Revs Down On Prior Quarter; CANB Down Near 40%, Hit Fresh 52 Week Lows; Separately Confirms No Material Change	02/04	MT
CanadaBis Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	29/03	CI
CanadaBis Capital's Fiscal Q1 Profit, Revenue Grows	02/01	MT
CanadaBis Capital Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	30/12	CI
CanadaBis Capital's Fiscal Q4 Profit, Revenue Rises; Up 5%	30/11	MT
CanadaBis Capital's Fiscal Q4 Profit, Revenue Rises	29/11	MT
CanadaBis Capital Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	28/11	CI
CanadaBis Capital CFO Steps Down, Replacement Appointed	01/23/01	MT
CanadaBis Capital Inc. Announces Appointment of Garfield Richards as Chief Financial Officer	01/23/01	CI
CanadaBis Capital's Fiscal Q3 Profit, Net Revenue Grows; Provides Outlook; Up 10.7%	29/23/29	MT
CanadaBis Capital's Fiscal Q3 Profit, Net Revenue Grows; Provides Outlook	29/23/29	MT
CanadaBis Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	28/23/28	CI
Canadabis Capital Inc. Launches New Super Slim Style Pre Roll Line	19/23/19	CI
Canadabis Capital Appoints Nicole Bacsalmasi Ll.B to the Board	01/23/01	CI
CanadaBis Capital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	01/23/01	CI
CanadaBis Capital Says Intends to Introduce More Products in 2023, Expects Sales Growth to Continue	24/23/24	MT
CanadaBis Capital Swings to Q1 Net Income from Year-Ago Loss; Net Revenue $5.15 Million Vs $1.85 Million	03/23/03	MT
CanadaBis Capital Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	30/22/30	CI
CanadaBis Capital Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	29/22/29	CI

Chart CanadaBis Capital Inc.

Duration

Period

More charts

Company Profile

CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Companyâs principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Companyâs subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.

Sector

Drug Retailers

Calendar

27/11/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Cannabis Product Retailers

	1st Jan change	Capi.
CANADABIS CAPITAL INC.	-76.47%	60.6L
GREEN THUMB INDUSTRIES INC.	+8.41%	277.66Cr
VERANO HOLDINGS CORP.	-7.65%	137.41Cr
GLASS HOUSE BRANDS INC.	+47.99%	52Cr
TERRASCEND CORP.	-12.73%	40Cr
HIGH TIDE INC.	+24.88%	16Cr
CANTOURAGE GROUP SE	-2.51%	9.36Cr
MARIMED INC.	-38.14%	6.47Cr